# Oral Sildenafil in Persistent Pulmonary Hypertension Secondary to Meconium Aspiration Syndrome in Newborns

> **NCT01757782** · PHASE4 · COMPLETED · sponsor: **Sir Takhtasinhji General Hospital** · enrollment: 96 (actual)

## Conditions studied

- Meconium Aspiration Syndrome
- Persistent Pulmonary Hypertension of Newborn

## Interventions

- **DRUG:** Oral Sildenafil
- **DRUG:** Placebo (distilled water)

## Key facts

- **NCT ID:** NCT01757782
- **Lead sponsor:** Sir Takhtasinhji General Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2012-08
- **Final completion:** 2012-09
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2022-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01757782

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01757782, "Oral Sildenafil in Persistent Pulmonary Hypertension Secondary to Meconium Aspiration Syndrome in Newborns". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01757782. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*